US2006127941A1PendingUtilityA1

Nuclear matrix protein fluid assay

56
Assignee: MATRITECH INCPriority: Oct 31, 1991Filed: Feb 2, 2006Published: Jun 15, 2006
Est. expiryOct 31, 2011(expired)· nominal 20-yr term from priority
G01N 33/575G01N 33/57585C07K 16/18G01N 33/5005G01N 33/6875G01N 33/5011Y10S435/961C07K 14/47G01N 2510/00G01N 2333/525
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a method for detecting and quantitating soluble nuclear matrix proteins in body fluids and extracellular media. The method is useful for monitoring the viability of cells and tissue, for evaluating the progress of a disease or its treatment, and for evaluating the cytotoxicity of unknown compounds. Also disclosed are methods for inducing the release of nuclear matrix proteins in soluble form from cells.

Claims

exact text as granted — not AI-modified
1 . A method for determining the degree of cell death in a tissue, said method comprising the step of: 
 detecting the concentration of body fluid-soluble nuclear matrix protein, or fragments thereof, released from the cells of said tissue, said concentration being indicative of the degree of cell death in said tissue.    
   
   
       2 .- 24 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.